aminocaproic acid has been researched along with Psoriasis in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuliev, NA | 1 |
| Rowe, E | 1 |
| Meffert, H | 1 |
| Wischnewsky, GG | 1 |
| Buchholz, W | 1 |
1 trial available for aminocaproic acid and Psoriasis
| Article | Year |
|---|---|
[Therapeutic trial with epsilon-aminocaproic acid in psoriasis vulgaris].
Topics: Administration, Oral; Adolescent; Adult; Aminocaproates; Aminocaproic Acid; Clinical Trials as Topic | 1985 |
1 other study available for aminocaproic acid and Psoriasis
| Article | Year |
|---|---|
[The treatment of psoriatic arthropathy with a combination of mefenamic and aminocaproic acids].
Topics: Adolescent; Adult; Aminocaproates; Aminocaproic Acid; Arthritis; Chronic Disease; Drug Evaluation; D | 1989 |